Focus: TELA Bio is a biotechnology company specializing in bioscaffold technology, primarily focused on surgical reconstruction applications. The company operates in a niche medical device/tissue engineering segment with products targeting breast reconstruction and hernia repair.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Stable — net -1 jobs in 30d
4 added, 5 removed. Backfill posture.
TELA Bio is a commercial-stage device company in growth mode, best suited for field-facing roles; limited transparency on financials, funding, and R&D intensity creates uncertainty about long-term stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for TELA Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from TELA Bio's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles